Home / Data / Women's Health Trial Tracker Women's Health Trial Tracker Women's Health Trial Tracker organizes records from ClinicalTrials.gov API v2 into a static table for transparent comparison. It preserves official source links and dates, marks missing enrichment, and adds deterministic grouping, change, recency, trend, or significance fields only where the documented inputs support them, without recommendations or unsupported claims.
Records 5,000
Last changed 10/10/2026
Update schedule 55 1 * * * UTC
Coverage 05/26/2000–10/09/2026 Record Record Date Vuga Group Change Status Recency Days Research Attention Score Screening for Atrial Fibrillation in Elderly Women Older Than 70 Years 07/05/2022 INTERVENTIONAL not-comparable 1,558.75 0 Effectiveness and Acceptability of Insertable Devices for Obstetric Fistula Management 07/06/2022 INTERVENTIONAL not-comparable 1,557.75 0 Levonorgestrel 52 mg IUD for Emergency Contraception and Same-Day Start 07/06/2022 INTERVENTIONAL not-comparable 1,557.75 0 A Multicenter Cohort Study on Maternal and Infant Microecology and New Targets for Pre-eclampsia Screening in China 07/06/2022 OBSERVATIONAL not-comparable 1,557.75 0 Mirvetuximab Soravtansine With Bevacizumab Versus Bevacizumab as Maintenance in Platinum-sensitive Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer 07/06/2022 INTERVENTIONAL not-comparable 1,557.75 0 ONC-392 and Pembrolizumab in Platinum Resistant Ovarian Cancer 07/06/2022 INTERVENTIONAL not-comparable 1,557.75 0 Bespoke ctDNA Assay for Recurrence and Treatment Response Monitoring in Advanced Epithelial Ovarian Cancer 07/06/2022 OBSERVATIONAL not-comparable 1,557.75 0 Prenatal Treatment of Congenital Cytomegalovirus Infection With Letermovir Versus Valaciclovir 07/06/2022 INTERVENTIONAL not-comparable 1,557.75 0 Effect of GH on the Blastocyst Euploid Rate in AMA Patients 07/07/2022 INTERVENTIONAL not-comparable 1,556.75 0 Study of Camrelizumab Plus Apatinib and Chemotherapy as Neoadjuvant Therapy in Participants With Triple Negative Breast Cancer (TNBC) 07/07/2022 INTERVENTIONAL not-comparable 1,556.75 0 Vitamin D, Epigallocatechin Gallate, D-chiro-inositol and Vitamin B6 in Uterine Fibroid 07/07/2022 INTERVENTIONAL not-comparable 1,556.75 0 Biological Matrices Versus Synthetic Meshes 07/08/2022 INTERVENTIONAL not-comparable 1,555.75 0 Assessment of the Breast Cosmesis Using Deep Neural Networks: an Exploratory Study (ABCD) 07/08/2022 OBSERVATIONAL not-comparable 1,555.75 0 Trial of FETO for Severe Congenital Diaphragmatic Hernia 07/11/2022 INTERVENTIONAL not-comparable 1,552.75 0 V503 in Chinese Girls 9-14 Years Old Versus Chinese Women 20-26 Years Old (V503-071) 07/11/2022 INTERVENTIONAL not-comparable 1,552.75 0 Physiological-based Pharmacokinetics Approach to Medication Exposure During Pregnancy and Breastfeeding 07/11/2022 OBSERVATIONAL not-comparable 1,552.75 0 Comprehensive Analysis of Spatial, Temporal and Molecular Patterns of Ribociclib Efficacy and Resistance in Advanced Breast Cancer Patients 07/11/2022 INTERVENTIONAL not-comparable 1,552.75 0 Mirvetuximab Soravtansine (MIRV) With Carboplatin in Second-line Treatment of Folate Receptor Alpha (FRα) Expressing, Platinum-sensitive Epithelial Ovarian Cancer 07/13/2022 INTERVENTIONAL not-comparable 1,550.75 0 Clinical Study on the Re-irradiation of Lateral Pelvic Recurrences of Gynecological Malignancies 07/14/2022 INTERVENTIONAL not-comparable 1,549.75 0 Postpartum Vaginal Estrogen for Breastfeeding Patients 07/14/2022 INTERVENTIONAL not-comparable 1,549.75 0 RCT of Pain Perception With Fast and Slow Tenaculum Application 07/14/2022 INTERVENTIONAL not-comparable 1,549.75 0 The Effect of Acupuncture on Nerve Pain Caused by Taxane (Chemotherapy) Treatment 07/14/2022 INTERVENTIONAL not-comparable 1,549.75 0 A Phase II Randomized, Open Label Non-inferiority Study of NiraParib Maintenance After 3 vs. 6 Cycles of Platinum-based Chemotherapy in completeLy debUlked Advanced HRDpositive High-grade Ovarian Cancer patientS in First Line Therapy 07/15/2022 INTERVENTIONAL not-comparable 1,548.75 0 Treatment Preventive for Pre-eclampsia by Acetylsalicylic Acid in Women Who Underwent Frozen Embryo Transfer 07/15/2022 INTERVENTIONAL not-comparable 1,548.75 0 First-in-human, Study of MATTISSE® Tissue Engineering Chamber in Adult Female Patients Undergoing Breast Reconstruction After Mastectomy for Cancer 07/15/2022 INTERVENTIONAL not-comparable 1,548.75 0 Breast Cancer Risk From Sonographic Glandular Tissue Component (or International GTC Study) 07/15/2022 OBSERVATIONAL not-comparable 1,548.75 0 Fetal Endoscopic Tracheal Occlusion (FETO) for Severe Congenital Diaphragmatic Hernia 07/18/2022 INTERVENTIONAL not-comparable 1,545.75 0 Autologous Heterotopic Fresh Ovarian Graft in Woman With LACC Eligible for Pelvic Radiotherapy Treatment. 07/18/2022 INTERVENTIONAL not-comparable 1,545.75 0 Intravenous Versus Oral Iron for Treating Iron-Deficiency Anemia in Pregnancy 07/18/2022 INTERVENTIONAL not-comparable 1,545.75 0 Preoperative Irradiation for Stage I Breast Cancer 07/19/2022 INTERVENTIONAL not-comparable 1,544.75 0 Letrozole With and Without Simvastatin for the Treatment of Stage I-III Hormone Receptor Positive, HER2 Negative Breast Cancer 07/19/2022 INTERVENTIONAL not-comparable 1,544.75 0 Visualizing Vascular Mechanisms of Lipedema 07/19/2022 OBSERVATIONAL not-comparable 1,544.75 0 Sacubitril/Valsartan in PriMAry preventIoN of the Cardiotoxicity of Systematic breaST canceR trEAtMent (MAINSTREAM) 07/19/2022 INTERVENTIONAL not-comparable 1,544.75 0 Safety and Efficacy of TAF to Prevent MTCT of HBV in Middle/Late Pregnancies With High HBV DNA Load 07/20/2022 OBSERVATIONAL not-comparable 1,543.75 0 Distribution of the Homologous Recombination-related (HRR) Genesmutationsand HRD in Breast Cancer 07/20/2022 OBSERVATIONAL not-comparable 1,543.75 0 Enhancing PrEP Outcomes Among Kenyan Adolescent Girls and Young Women With a Novel Pharmacy-based PrEP Delivery Platform 07/20/2022 INTERVENTIONAL not-comparable 1,543.75 0 Feasibility of [11C]Acetate-PET in LAM and TSC 07/20/2022 INTERVENTIONAL not-comparable 1,543.75 0 Safety and Efficacy of Anti-CD47, ALX148 in Combination With Liposomal Doxorubicin and Pembrolizumab in Recurrent Platinum-resistant Ovarian Cancer 07/20/2022 INTERVENTIONAL not-comparable 1,543.75 0 Lymphedema After Gyneco-oncologic Treatment 07/22/2022 INTERVENTIONAL not-comparable 1,541.75 0 Comparing Two Prophylactic Antibiotic Protocols in Women With Term Prolonged Pre-labor Rupture of Membrane and Preterm Labor 07/22/2022 INTERVENTIONAL not-comparable 1,541.75 0 Compare Adjuvant Monotherapy With Endocrine or Accelerated Partial Breast Irradiation After Lumpectomy 07/25/2022 INTERVENTIONAL not-comparable 1,538.75 0 Descriptive Analysis of Serum Immunological Markers During an Euploid Frozen Embryo Transfer in a Natural Cycle. 07/25/2022 OBSERVATIONAL not-comparable 1,538.75 0 Enhancing Capacity in Churches to Implement PA Programs 07/26/2022 INTERVENTIONAL not-comparable 1,537.75 0 Clinical Study of Camrelizumab Combined With TCb Versus TCb in Neoadjuvant Treatment of Triple-negative Breast Cancer 07/27/2022 INTERVENTIONAL not-comparable 1,536.75 0 Comparison of the Efficacy of Different Treatment Methods in Patients With Carpal Tunnel Syndrome 07/27/2022 INTERVENTIONAL not-comparable 1,536.75 0 A GnRH Agonist IN Pre-menopausal Women STudy to Treat Severe Polycystic Liver Disease 07/28/2022 INTERVENTIONAL not-comparable 1,535.75 0 Carbon Ion Radiation Therapy in the Treatment of Mucous Melanomas of the Female Lower Genital Tract 07/28/2022 INTERVENTIONAL not-comparable 1,535.75 0 Neoadjuvant Radiation in Locally Advanced Breast Cancer 07/29/2022 INTERVENTIONAL not-comparable 1,534.75 0 Evaluation of Endometriosis With 18F-fluorofuranylnorprogesterone PET / MRI 07/29/2022 INTERVENTIONAL not-comparable 1,534.75 0 Exenatide Pharmacokinetics and Pharmacodynamics in Gestational Diabetes 08/01/2022 INTERVENTIONAL not-comparable 1,531.75 0
Source U.S. National Library of Medicine, ClinicalTrials.gov API v2 · official record · retrieved 10/10/2026 · upstream last modified 10/10/2026
Licence United States government work; public domain unless the source record says otherwise. Source: U.S. National Library of Medicine
Required notice Study records are informational and do not provide diagnosis, treatment advice, or an assessment of individual risk. What we add We compute Vuga Group, Change Status, Recency Days, Research Attention Score using the documented compute method. · methodology